Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03539536
Brief Title: Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

First Submitted : May 17, 2018
First Submitted that Met QC Criteria : May 17, 2018
First Posted : May 29, 2018

Last Update Submitted that Met QC Criteria : July 24, 2021
Last Update Posted : July 27, 2021